PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
09-Mar-2020 Kancera provides an update on the development of the drug candidate KAND145 Kancera AB
09-Mar-2020 Hansa Biopharma announces long term follow-up data that demonstrates 2-year graft survival of 89% after imlifdase treatment and transplantation Hansa Biopharma AB
09-Mar-2020 Marinomed extends the range of Marinosolv® applications Marinomed Biotech AG
09-Mar-2020 SHIONOGI ANNOUNCES LAUNCH OF MULPLEO® (LUSUTROMBOPAG) IN THE UK, FOR THE TREATMENT OF SEVERE THROMBOCYTOPENIA IN ADULT PATIENTS WITH CHRONIC LIVER DISEASE UNDERGOING INVASIVE PROCEDURES Shionogi & Co., Ltd
06-Mar-2020 Orexo submits application for vorvida® to the FDA to enable commercialization in the US Orexo AB
06-Mar-2020 Biotalys announces second closing of €45 million Series C financing round Biotalys
06-Mar-2020 vTv Therapeutics has potential to be strong player in up-and-coming oral drug market for type 1 diabetics, says GlobalData vTv Therapeutics
06-Mar-2020 Abbott Aims to Optimize TAVI Implants with European Approval of FlexNav™ Delivery System for the Company's Portico™ Valve Abbott
06-Mar-2020 New approach for immediate pain free diagnosis of oral cancers Zilico Ltd
06-Mar-2020 Biotalys announces second closing of €45 million Series C financing round Biotalys
06-Mar-2020 NuCana Receives Positive Opinion for Orphan Drug Designation in the European Union for Acelarin (NUC-1031) for the Treatment of Patients with Biliary Tract Cancer NuCana plc
06-Mar-2020 Hospital PUC-Campinas Celso Pierro joins Patient Network Explorer, expanding Clinerion’s existing patient coverage in Brazil. Clinerion Ltd.
06-Mar-2020 Birmingham researcher awarded £1.68m to fund research in ‘raised brain pressure’ University of Birmingham
06-Mar-2020 GLOBAL GROWTH OF AROUND $900 MILLION A YEAR FOR DATA VISUALISATION MARKET Zegami
06-Mar-2020 As coronavirus spreads, mitigation may be better strategy than quarantine, says GlobalData GlobalData
06-Mar-2020 New hVIVO contract signed with a European Biotech Company Open Orphan plc
04-Mar-2020 Notice of Preliminary Results Ergomed plc
04-Mar-2020 Interim Results for the six months ended 31 December 2019 Allergy Therapeutics plc
04-Mar-2020 Abcam extends assay and labelling capabilities with the acquisition of Marker Gene Technologies Abcam
04-Mar-2020 New disinfection spray from Lipidor and Aurena Laboratories Lipidor AB